Reshma KewalramaniFiled
CEO & PresidentExecutiveDirectorCIK 1735944
- VRTXVERTEX PHARMACEUTICALS INC / MACEO & Presidentfiled Mar 3, 2026
Net · 12 months
-$19.7M
Open-market buys − sales
Sold · 12 months
$19.7M
$0 in 90d · 18 sales on record
Bought · 12 months
$0
$0 in 90d · 2 buys on record
Under 10b5-1
100%
Share of sale value under a trading plan
Last trade
Feb 27, 2026
Filed Mar 3, 2026 · 43 rows
Monthly open-market value · 24 months Filed
- Bought (open market)
- Sold (open market)
Unusual activity Estimated
Whale score 88Whale watch
- 65Insider overlapMar 27, 2026
Sen. Alan Armstrong bought VRTX 28 days after its CEO sold $7.7M
Details
- Politician
- Alan Armstrong
- Ticker
- VRTX
- Asset
- Vertex Pharmaceuticals Incorporated - Common Stock
- Tx type
- buy
- Tx date
- Mar 27, 2026
- Filing date
- Jul 21, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Amount mid
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 116
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_sale","tx_date":"2026-02-27","shares":15580,"price":495.38,"value":7718020.4,"is_10b5_1":true}
- Days between
- 28
- Opposite side
- Yes
- 28Exec saleFeb 27, 2026
VRTX CEO Reshma Kewalramani sold $7.7M (10b5-1 plan)
Details
- Insider
- Reshma Kewalramani
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Tx date
- Feb 27, 2026
- Shares
- 15,580
- Price
- $495
- Value
- $7.7M
- Is 10b5 1
- Yes
- 50Insider overlapJan 29, 2026
Rep. David J. Taylor sold VRTX 29 days before its CEO sold $7.7M
Details
- Politician
- David J. Taylor
- Ticker
- VRTX
- Asset
- Vertex Pharmaceuticals Incorporated - Common Stock (VRTX)
- Tx type
- sell
- Tx date
- Jan 29, 2026
- Filing date
- Feb 2, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Amount mid
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 4
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_sale","tx_date":"2026-02-27","shares":15580,"price":495.38,"value":7718020.4,"is_10b5_1":true}
- Days between
- -29
- Opposite side
- No
- 50Insider overlapAug 7, 2025
Rep. David J. Taylor bought VRTX 1 day after its CEO bought $2.2M
Details
- Politician
- David J. Taylor
- Ticker
- VRTX
- Asset
- Vertex Pharmaceuticals Incorporated - Common Stock (VRTX)
- Tx type
- buy
- Tx date
- Aug 7, 2025
- Filing date
- Sep 2, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Amount mid
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 26
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_buy","tx_date":"2025-08-06","shares":5710,"price":389.95,"value":2226614.5,"is_10b5_1":false}
- Days between
- 1
- Opposite side
- No
- 65Exec buyAug 6, 2025
VRTX CEO Reshma Kewalramani bought $2.2M on the open market
Details
- Insider
- Reshma Kewalramani
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_buy
- Tx date
- Aug 6, 2025
- Shares
- 5,710
- Price
- $390
- Value
- $2.2M
- Is 10b5 1
- No
- 63Exec buyAug 6, 2025
VRTX CEO Reshma Kewalramani bought $1.7M on the open market
Details
- Insider
- Reshma Kewalramani
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_buy
- Tx date
- Aug 6, 2025
- Shares
- 4,290
- Price
- $389
- Value
- $1.7M
- Is 10b5 1
- No
- 28Exec saleNov 8, 2024
VRTX CEO Reshma Kewalramani sold $7.8M (10b5-1 plan)
Details
- Insider
- Reshma Kewalramani
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Tx date
- Nov 8, 2024
- Shares
- 15,198
- Price
- $515
- Value
- $7.8M
- Is 10b5 1
- Yes
- 65Insider overlapOct 23, 2024
Rep. Julia Letlow bought VRTX 16 days before its CEO sold $7.8M
Details
- Politician
- Julia Letlow
- Ticker
- VRTX
- Asset
- Vertex Pharmaceuticals Incorporated - Common Stock (VRTX)
- Tx type
- buy
- Tx date
- Oct 23, 2024
- Filing date
- Jan 13, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Amount mid
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 447
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_sale","tx_date":"2024-11-08","shares":15198,"price":515,"value":7826970,"is_10b5_1":true}
- Days between
- -16
- Opposite side
- Yes
Transactions
Independent third-party platform; not affiliated with or endorsed by any member of Congress. Data sourced from publicly available filings and records. Portfolio, holdings, returns, and allocations are estimates and may differ from actual values. Informational and educational only; not investment advice. Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4; the whale score is a model ranking of that filed activity.